IP Library Granted Patent US 9,044,612
Granted Patent B2
US 9,044,612 · App. 14/042,515 · Granted Jun 2, 2015

Apparatus and method for extending implant life using a dual power scheme

Inventors: Adi Mashiach (Tel Aviv, IL); Carsten Mueller (St. Ingbert, DE)
A61N1/36117A61N1/0551A61N1/36A61N1/36003A61N1/36075A61N1/3606A61N1/36135A61N1/36146A61N1/3601A61N1/3611A61N1/37211A61N1/0504A61N1/3605A61N1/0548A61N1/0526A61N1/05A61N1/3787A61N1/37223A61B5/6833A61B5/6876A61N1/3756A61B5/0031A61B5/11A61B5/113A61F5/566A61B5/4519A61B5/4818A61B5/682A61B5/6822A61N1/0514A61N1/0553A61N1/36057A61N1/37229A61B2562/164A61N2/006A61N2/02A61N1/37235A61N1/3727A61N1/0529
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,612
App. No.
14/042,515
Granted
Jun 2, 2015
Kind
B2
Abstract

A device according to some embodiments may include a housing configured for location external to a body of a subject. The device may also include at least one processor associated with the housing and configured for electrical communication with a power source, and an antenna associated with the at least one processor. The at least one processor may be configured to communicate with an implant circuit located within the body of the subject, cause the implant circuit to receive power in a first power mode and in a second power mode, wherein a first level of power delivered in the first power mode is less than a second level of power delivered in the second power mode, and wherein during a therapy period, power delivery in the first mode occurs over a total time that is greater than about 50% of the therapy period.

Claims (25)

1. A device comprising:

a housing configured for location external to a body of a subject; and

at least one processor associated with the housing and configured for electrical communication with a power source; and

an antenna associated with the at least one processor;

the at least one processor being configured to:

communicate with an implant circuit located within the body of the subject,

cause the implant circuit to receive power in a first power mode and in a second power mode, wherein

a first level of power delivered in the first power mode is less than a second level of power delivered in the second power mode,

the first level of power delivered in the first power mode is lower than a power level required to cause modulation of at least one nerve in the body of the subject,

the second level of power delivered in the second power mode is at least as great as the power level required to cause modulation of the at least one nerve in the body of the subject, and

during a therapy period, power delivery in the first power mode occurs over a total time that is greater than about 50% of the therapy period.

2. The device of claim 1 , wherein the implant circuit is associated with electrodes, and wherein during the first power mode, the at least one processor causes a first alternating current signal to supply power to the implant circuit while the implant circuit is substantially restricted from supplying direct current to the electrodes , and wherein during the second power mode, the at least one processor causes a second alternating current signal to supply power to the implant circuit for conversion to direct current to be supplied to the electrodes.

3. The device of claim 1 , wherein the implant circuit is substantially restricted from supplying direct current to the electrodes by a diode.

4. The device of claim 2 , wherein during the first power mode, the first alternating current signal is supplied at a lower voltage than the second alternating current signal supplied during the second power mode.

5. The device of claim 2 , wherein the first and the second alternating current signals are transmitted to the implant circuit via the antenna associated with the at least one processor.

6. The device of claim 1 , wherein the implant circuit is associated with electrodes, and

wherein the at least one processor is further configured to cause an alternating current signal to supply power to the implant circuit for conversion to direct current to be supplied to the electrodes, and

wherein during the first power mode, a first power mode pulse length of the alternating current signal is shorter than a pulse length required to stimulate a nerve to cause a contraction of a muscle associated with the nerve through the electrodes associated with the implant circuit, and during the second power mode, a second power mode pulse length of the alternating current signal is at least as long as the pulse length required to stimulate the nerve to cause a contraction of the muscle associated with the nerve through the electrodes associated with the implant circuit.

7. The device of claim 6 , wherein the first power mode pulse length is less than 50 microseconds, and the second power mode pulse length is greater than 50 microseconds.

8. The device of claim 6 , wherein the first power mode pulse length is less than 500 nanoseconds, and the second power mode pulse length is greater than 50 microseconds.

9. The device of claim 1 , wherein the implant circuit is associated with electrodes, and

wherein the at least one processor is further configured to cause an alternating current signal to supply power to the implant circuit for conversion to direct current to be supplied to the electrodes, and

wherein during the first power mode, a first power mode current amplitude of the alternating current signal is lower than a current amplitude required to stimulate a nerve to cause a contraction of a muscle associated with the nerve through the electrodes associated with the implant circuit, and during the second power mode, a second power mode current amplitude of the alternating current signal is at least as great as a current amplitude required to stimulate the nerve to cause a contraction of the muscle associated with the nerve through the electrodes associated with the implant circuit.

10. The device of claim 1 , wherein the total time of power delivery in the first mode is greater than about 90% of the therapy period.

11. The device of claim 1 , wherein the total time of power delivery in the first mode is greater than about 95% of the therapy period.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: NYXOAH S.A.
To: MAN & SCIENCE S.A.
Reel/Frame 049305/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2018
From: MASHIACH, ADI
To: NYXOAH SA
Reel/Frame 047149/0121 →
Continuity (4)
Division 13629793 · Sep 28, 2012
Provisional Application 61541651 · Sep 30, 2011
Provisional Application 61657424 · Jun 8, 2012
Related Publication 20140100635A1 · Apr 10, 2014